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PREDICTORS OF HEALTH STATUS CHANGE AMONG
PATIENTSTREATED WITH A CALCIUM ANTAGONIST-
OR AN ATENOLOL-LED HYPERTENSION STRATEGY IN
THE INTERNATIONALVERAPAMIL SR-TRANDOLAPRIL
STUDY (INVEST)
Ried LD1, Gandhi PK2
1University of Florida, Gainesville, FL, USA, 2University of
Florida-Gainsville, Gainsville, FL, USA
OBJECTIVES: To examine associations between 1) hypertension
treatment strategy; 2) demographic characteristics; and 3) change
in utility scores for SF-6D dimensions with patients’ self-reported
change in health status. METHODS: INVEST patients random-
ized to a calcium antagonist- or atenolol-led high blood pressure
treatment strategy residing in the United States were surveyed
between April 1 and October 31, 1999 (N = 2317). The survey
contained the SF-36 HRQoL items. Baseline and 12 month
SF-6D utility indices were calculated for study subjects who
completed both surveys (n = 1010). Subjects who indicated that
their health was better or worse compared to last year were
classified as having an important change in their self-reported
health status. Baseline and 1-year mean SF-6D indices and utility
scores for each SF-6D dimension were compared within each
treatment strategy using paired t-tests. Independent t-tests
assessed differences between treatment strategy and utility scores
for each SF-6D dimension and for change in SF-6D index. Hier-
archical logistic regression models were used to identify variables
associated with health status change. RESULTS: Mental health,
role limitation, and pain utility scores were improved among
those assigned to the verapamil-SR-led strategy; only mental
health was improved among those assigned to the atenolol-led
strategy (p < 0.05). Patients reporting worsened health status
were more likely to have negative utility score changes on the
physical and social functioning, role limitation, pain, and vitality
domains. Patients reporting improved health status had positive
utility score changes in the mental health, social functioning, role
limitation, pain, and vitality domains. Treatment strategy was
not associated with health status change. Non-Caucasians were
more likely to report improved health status. CONCLUSIONS:
Verapamil-SR hypertension treatment was associated with utility
score improvements in multiple SF-6D domains. However, drug
treatment’s effect was apparently not noticeable enough for it to
be associated with patients’ judgments that their health improved
or worsened.
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SOCIODEMOGRAPHIC AND CARDIOVASCULAR RISK
FACTORS INFLUENCES ON EQ-5D SOCIAL PREFERENCES
SCORES AND SELF-REPORTED HEALTH: A GENERAL
POPULATION SURVEY IN ARGENTINA
Augustovski FA, Irazola V, Caporale JE, Rubinstein A
Instituto de Efectividad Clínica y Sanitaria (IECS), Buenos Aires,
Argentina
OBJECTIVES:To evaluate the influence of demographic, socio-
economic, and risk factors variables on the EQ-5D time trade-off
[TTO] and visual analogue scale [VAS] population values as well
as in the self-reported health by VAS [VAS-SR] in Argentina.
METHODS: We included data from 41,392 adults in the first
National Risk Factor [RF] Survey (2005), a general population
nationally representative sample. Survey variables included self-
reported sociodemographic parameters and RF (diabetes [DBT],
high blood pressure [HBP], dyslipemia [DLP], obesity [OB],
smoking [SMK], healthy diet [HD], physical activity [PA], as well
as the EQ-5D instrument (including the descriptive system and
the VAS-SR item). TTO and VAS preference values were mapped
from a local EQ-5D Value study. We assessed the independent
relationships between EQ-5D scores (TTO and VAS) as well as
the VAS-SR with sociodemographic variables and RF. We used
multivariable linear regression modeling. We considered clini-
cally meaningful a coefficient of >=0.02. RESULTS: Final models
included 33,964 subjects, representing 17,586,759 Argentineans,
and had an R2 of 0.16–0.19. In fully adjusted models, the fol-
lowing variables were statistically, consistently, and clinically
associated with both TTO and VAS EQ-5D scores as well as
VAS-SR: age, gender, income, selected provinces, health cover-
age, DBT, HBP, DLP, PA, with coefficients ranging from 0.02 to
0.09. Though there were statistical differences among housing,
household, education, employment status, gender of household
head, SMK, OB, and HD subgroups, they had a small magnitude
(coefficients < 0.02) or were not consistently associated with
TTO/VAS/VAS-SR. CONCLUSIONS: In Argentina, in addition
to sociodemographic factors, diabetes, hypertension, physical
activity and dyslipemia, were significantly and strongly associ-
ated with scores on the EQ-5D as well as with self-reported VAS.
This is, to our knowledge, the first study in Latin America that
evaluates the determinants of EQ-5D weights and VAS-SR using
a general population health survey as well as locally derived
weights.
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ACCEPTABILITY OFTECHNOLOGICALTREATMENT AND
THE EFFECT OF RESPONDENT CHARACTERISTICS ON
TREATMENT PREFERENCE
van Til JA, IJzerman MJ
University of Twente, Enschede,The Netherlands
OBJECTIVES: Surgical and/or technological treatment such as
nerve stimulation is becoming increasingly popular in the treat-
ment of acquired ankle-foot deformity in rehabilitation medicine.
It is known that the older and impaired population can be
technology adverse. The purpose of this study was to determine
the acceptability of invasive technological treatment to patients
and healthy controls and to study the influence of respondent
characteristics on the preference for treatment. METHODS: A
total of 204 Respondents participated in a conjoint analysis
discrete choice experiment. Ankle-foot impairment was related
to either central neurological (n = 58), or peripheral neurological
disease (n = 54). Healthy respondents were also included
(n = 92). The amount of information on the decision problem
which was provided to the healthy controls varied. A multino-
mial logit regression model was used to estimate part worth
utilities for the attribute levels of 8 criteria (treatment duration,
treatment impact, duration and ease of use of aids, complication
severity and rate, comfort & cosmetics, result type and success
rate on choice of treatment) with 2–4 levels and attribute impor-
tance and to study the influence of age, gender, educational level,
cognitive impairment, physical impairment and extent of infor-
mation provision prior to the experiment on the fit of the regres-
sion model. RESULTS: All treatment attributes have a significant
influence on treatment choice. Most important are impact of
treatment (20%) and duration & ease of use of aids (19%). No
operation (0.46) and minimal use of aids (0.39) is preferred. Age
has a significant influence (W = 4.92; p = 0.026). No effect of
cognitive impairment or ankle-foot impairment was found.
CONCLUSIONS: It could be concluded that 1) surgical treat-
ment and the use of technology are considered negative aspects of
treatment, and 2) age-matched healthy respondents’ preferences
can be used as predictors for cognitively and physically impaired
patients.
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